ALTERITY THERAPEUTICS LTD
ATHE PRNADCIK 0001131343 · Pharmaceutical Preparations · Nasdaq, OTC
- PRANA BIOTECHNOLOGY LTD (until 2019-04-08)
Revenue (TTM)
201.17K
+51.9% YoY
FY Jun 2025
Net Income (TTM)
—
FY Jun 2025
EPS Diluted (TTM)
−0.19
+63.5% YoY
FY Jun 2025
Gross Margin
—
FY Jun 2025
Operating Margin
—
FY Jun 2025
Net Margin
—
FY Jun 2025
Free Cash Flow (TTM)
—
FY Jun 2025
Cash
33.16M
FY Jun 2025
Total Debt
—
FY Jun 2025
Shares Outstanding
9.13B sh
FY Jun 2025